Looks like you clickedhttps://www.urotoday.com/conference-highlights/asco-gu-2019/asco-gu-2019-prostate-cancer/110238-asco-gu-2019-initial-results-from-checkmate-650-a-phase-ii-study-of-nivolumab-plus-ipilimumab-for-the-treatment-of-metastatic-castration-resistant-prostate-cancer.html?utm_source=newsletter_6849&utm_medium=email&utm_campaign=draft-for-approval-gu-round-up
If you do not want to visit that page, you can close this browser tab.
